Hepatocellular carcinoma and Hepatic atrophy

---

Gender of people who have Hepatocellular Carcinoma and experienced Hepatic Atrophy *:

• female: 50 %
• male: 50 %

Age of people who have Hepatocellular Carcinoma and experienced Hepatic Atrophy *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 0.0 %
• 40-49: 0.0 %
• 50-59: 21.43 %
• 60+: 78.57 %

Common co-existing conditions for these people *:

1. High Blood Pressure: 2 people, 11.76%

Common drugs taken by these people *:

1. Tecentriq: 5 people, 29.41%
2. Avastin: 5 people, 29.41%
3. Nexavar: 3 people, 17.65%
4. Lenvima: 3 people, 17.65%
5. Norvasc: 2 people, 11.76%
6. Cisplatin: 1 person, 5.88%
7. Cabometyx: 1 person, 5.88%
8. Amlodipine: 1 person, 5.88%

Common symptoms for these people *:

1. Ascites (accumulation of fluid in the abdominal cavity): 7 people, 41.18%
2. Renal Impairment (severely reduced kidney function): 4 people, 23.53%
3. Hepatic Failure (liver failure): 3 people, 17.65%
4. Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 3 people, 17.65%
5. Enterocolitis Infectious: 3 people, 17.65%
6. Blood Bilirubin Increased: 3 people, 17.65%
7. Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 3 people, 17.65%
8. Hair Loss: 3 people, 17.65%
9. Cellulitis (infection under the skin): 2 people, 11.76%
10. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 11.76%

Do you take medications and have Hepatic atrophy?

- Check whether Hepatic atrophy is associated with a drug or a condition